Morepen Laboratories Limited
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
Key metrics
Price as of 2026-07-17
Stock price
₹58.90
Market cap
3,227 Cr
Stock P/E
28.9
P/B
2.59
Dividend yield
0.3%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 401 Cr | 823 Cr | 1,267 Cr | 1,690 Cr | 455 Cr | 893 Cr | 453 Cr | 466 Cr | 425 Cr | 412 Cr | 484 Cr | 485 Cr |
| Operating expenses (approx.) | 373 Cr | 757 Cr | 1,147 Cr | 1,518 Cr | 400 Cr | 789 Cr | 411 Cr | 419 Cr | 397 Cr | 350 Cr | 434 Cr | 452 Cr |
| EBITDA | 29 Cr | 65 Cr | 120 Cr | 173 Cr | 55 Cr | 104 Cr | 41 Cr | 47 Cr | 29 Cr | 61 Cr | 50 Cr | 33 Cr |
| OPM % | 7.1% | 7.9% | 9.5% | 10.2% | 12.1% | 11.7% | 9.2% | 10.1% | 6.7% | 14.9% | 10.4% | 6.8% |
| Other income | 2 Cr | 6 Cr | 10 Cr | 14 Cr | 3 Cr | 8 Cr | 5 Cr | 5 Cr | 4 Cr | 5 Cr | 4 Cr | 8 Cr |
| Interest | 0.28 Cr | 0.74 Cr | 3 Cr | 4 Cr | 1 Cr | 2 Cr | 1 Cr | 5 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr |
| Depreciation | 8 Cr | 15 Cr | 24 Cr | 33 Cr | 6 Cr | 8 Cr | 5 Cr | 16 Cr | 9 Cr | 11 Cr | 10 Cr | 6 Cr |
| Profit before tax | 21 Cr | 49 Cr | 93 Cr | 135 Cr | 48 Cr | 94 Cr | 35 Cr | 26 Cr | 16 Cr | 46 Cr | 35 Cr | 23 Cr |
| Tax % | 28.7% | 27.0% | 27.2% | 28.6% | 24.9% | 24.6% | 24.2% | 21.0% | 26.5% | 10.2% | 22.4% | 32.6% |
| Net profit | 15 Cr | 36 Cr | 68 Cr | 96 Cr | 36 Cr | 71 Cr | 27 Cr | 20 Cr | 11 Cr | 41 Cr | 28 Cr | 16 Cr |
| EPS (₹) | ₹0.29 | ₹0.71 | ₹1.33 | ₹1.88 | ₹0.71 | ₹1.36 | ₹0.49 | ₹0.35 | ₹0.20 | ₹0.75 | ₹0.50 | ₹0.28 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 769 Cr | 853 Cr | 1,188 Cr | 1,547 Cr | 1,418 Cr | 1,690 Cr | 1,812 Cr | 1,806 Cr | Sign in for TTM |
| Operating expenses (approx.) | 697 Cr | 775 Cr | 1,057 Cr | 1,400 Cr | 1,338 Cr | 1,532 Cr | 1,619 Cr | 1,633 Cr | Sign in for TTM |
| EBITDA | 71 Cr | 78 Cr | 131 Cr | 147 Cr | 80 Cr | 159 Cr | 192 Cr | 173 Cr | Sign in for TTM |
| OPM % | 9.3% | 9.1% | 11.0% | 9.5% | 5.6% | 9.4% | 10.6% | 9.6% | Sign in for TTM |
| Other income | 4 Cr | 9 Cr | 12 Cr | 10 Cr | 6 Cr | 14 Cr | 18 Cr | 21 Cr | Sign in for TTM |
| Interest | 2 Cr | 2 Cr | 2 Cr | -7 Cr | 2 Cr | 4 Cr | 8 Cr | 16 Cr | Sign in for TTM |
| Depreciation | 40 Cr | 37 Cr | 30 Cr | 28 Cr | 28 Cr | 33 Cr | 29 Cr | 36 Cr | Sign in for TTM |
| Profit before tax | 29 Cr | 39 Cr | 99 Cr | 127 Cr | 56 Cr | 135 Cr | 155 Cr | 120 Cr | Sign in for TTM |
| Tax % | 1.2% | 14.1% | 1.4% | 19.7% | 30.6% | 28.6% | 23.9% | 20.2% | Sign in for TTM |
| Net profit | 29 Cr | 34 Cr | 97 Cr | 102 Cr | 39 Cr | 96 Cr | 118 Cr | 95 Cr | Sign in for TTM |
| EPS (₹) | ₹0.64 | ₹0.75 | ₹2.16 | ₹2.26 | ₹0.77 | ₹1.88 | ₹2.20 | ₹1.73 | Sign in for TTM |
| Dividend payout % | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 11.4% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 90 Cr | 90 Cr | 90 Cr | 96 Cr | 102 Cr | 102 Cr | 110 Cr | 110 Cr |
| Reserves | 163 Cr | 194 Cr | 335 Cr | 0.0000 Cr | 651 Cr | 745 Cr | 1,047 Cr | 1,137 Cr |
| Borrowings | 11 Cr | 12 Cr | 16 Cr | 19 Cr | 25 Cr | 29 Cr | 54 Cr | 61 Cr |
| Other liabilities | 331 Cr | 342 Cr | 386 Cr | 417 Cr | 333 Cr | 417 Cr | 538 Cr | 628 Cr |
| Total liabilities | 619 Cr | 662 Cr | 847 Cr | 1,033 Cr | 1,110 Cr | 1,293 Cr | 1,778 Cr | 1,936 Cr |
| Fixed assets (net) | 145 Cr | 132 Cr | 128 Cr | 145 Cr | 167 Cr | 213 Cr | 317 Cr | 381 Cr |
| CWIP | 0.0000 Cr | 0.0000 Cr | 2 Cr | 14 Cr | 17 Cr | 24 Cr | 28 Cr | 22 Cr |
| Investments | 118 Cr | 119 Cr | 119 Cr | 118 Cr | 0.0000 Cr | 1 Cr | 85 Cr | 124 Cr |
| Other assets | 284 Cr | 349 Cr | 493 Cr | 677 Cr | 756 Cr | 889 Cr | 1,160 Cr | 1,164 Cr |
| Total assets | 619 Cr | 662 Cr | 847 Cr | 1,033 Cr | 1,110 Cr | 1,293 Cr | 1,778 Cr | 1,936 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | -58 Cr | -91 Cr | 73 Cr | 32 Cr | 33 Cr |
| Cash from investing | — | — | — | -32 Cr | -47 Cr | -83 Cr | -322 Cr | -123 Cr |
| Cash from financing | — | — | — | 64 Cr | 144 Cr | 5 Cr | 300 Cr | 97 Cr |
| Net cash flow | — | — | — | -26 Cr | 6 Cr | -5 Cr | 10 Cr | 7 Cr |
| Free cash flow (OCF − Capex) | — | — | — | -103 Cr | -127 Cr | 2 Cr | -92 Cr | -53 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019Standalone only | Mar 2020Standalone only | Mar 2021Standalone only | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 12.4% | 14.5% | 23.6% | 124.9% | 6.6% | 14.3% | 13.2% | 10.4% |
| ROE % | 0.0% | 0.0% | 22.9% | 0.0% | 5.1% | 0.0% | 0.0% | 0.0% |
| Debtor days | 62 | 56 | 51 | 56 | 68 | 70 | — | — |
| Inventory days | 96 | 117 | 100 | 118 | 107 | 103 | 109 | 95 |
| Days payable | 167 | 140 | 113 | 99 | 106 | 122 | — | — |
| Cash conversion cycle | -8 | 33 | 38 | 74 | 69 | 51 | 109 | 95 |
| Debt / equity | 0.04 | 0.00 | 0.04 | 0.03 | 0.03 | 0.03 | 0.05 | 0.05 |
| Current ratio | 0.88 | 1.06 | 1.31 | 1.68 | 2.35 | 2.21 | 2.32 | 2.37 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.08 | 0.14 | 0.17 |
Compare with peers
Loading peers…